3H developed ‘Insight Gateway’ – The New Ray of Hope for Oncology Patients
The word ‘Cancer’ looms fear and anxiety in the minds of the general public. The insidious onset and the possible devastative outcome which this disease can bring about, makes it one of the most dreaded diseases by mankind. However today, this perception is slowly declining adding a ray of hope into the lives of cancer patients through early detection and novel treatment modalities. Research has confirmed the importance of starting treatment without any delay for cancer patients as there could be adverse consequences by significantly impacting on patient mortality due to delayed treatment. Globally, there are many clinical trials being conducted for various indications of cancer with an aim to prolong life, improve the quality of life and defeat death. 3H Group as part of a Life Science company connects human health with happiness and ‘Insight Gateway’ is our latest give-way to show care and support to our cancer patients during this critical phase of the pandemic.
‘Inside Gateway’ Participating in Oncology Trials just got easier in Japan: Insight Gateway is the latest addition by 3H Clinical Trials and Hatch Healthcare. It is a ‘clinical trial introduction system’ which supports patient profiles, questionnaires, chat messages and appointment scheduling and is a great tool when clubbed with the Oncolo website. The Oncolo website by 3H, is the first Japanese website completely dedicated to educating and building awareness about cancer and it has a registry of the ongoing clinical trials in cancer. This website has become a great resource for cancer patients, their families as well as medical professionals. It has recently obtained the HON-code certification, recognising this platform as a reliable medical and health information access website. With the rolling in of ‘Inside Gateway’ the horizons of Oncolo has been broadened and now patients can register themselves on this platform to have a chat with an Oncologist to understand their eligibility in joining an oncology clinical trial of their choice. It has been developed in partnership with the Department of Advanced Medicine National Cancer Research Centre and facilitates in confirming the eligibility of cancer patients to a clinical trial even prior to visiting a medical facility. It also shares information with patients on available clinical trials to suit each patient`s specific circumstances.
In August 2020, Japan’s regulation on ‘Registration of clinical trial implementation status’ was relaxed which made it easy for the public to participate in clinical trials. Thus, with these regulatory changes, the public now has more access to information and it is a great move, especially for these vulnerable cancer patients giving them more opportunity and access to knowing about the ongoing clinical trials.
Why ‘Inside Gateway’ is a Blessing for Cancer Patients: Being diagnosed with cancer is not easy emotionally, it brings a range of strong emotions from fear to anger to disbelief and sadness. Valuable time is usually lost by cancer patients in independently trying to find clinical trials which they can enrol into. This usually happens by visiting trial centres and taking individual appointments to screen their eligibility. Participation in oncology trials are rather strict and in most instances they are not able to take part based on their medical examination. Patients from rural areas are especially at a loss putting them in difficulty, finding suitable clinical trials which they can participate in.
Inside Gateway allows cancer patients to directly consult a specialist online to discuss about their eligibility to participate in a clinical trial conducted by the National Cancer Research Centre. This platform has made it easy for patients to apply for the website listed clinical trials and is a very quick process to consult and make an appointment with a specialist. Following the specialist consultation, the doctor can judge eligibility for clinical trial participation and introduce other relevant clinical trials based on the patients’ profile, questionnaire results, and chat history.
3H’s Support in Health Care Services: As a Life Science Company, 3H connects human health with happiness. The company offers comprehensive support for Pharmaceutical and Drug Development Companies to proactively conduct their clinical trials with assistance in patient recruitment, patient surveys, development activities and tech-related health support providing novel solutions to suit the demand and industry needs. This Inside Gateway by 3H is the first of its kind in Japan and it is a timely intervention during this pandemic to help through clinical trial referrals which allows cancer patients to consult with a specialist online to understand their eligibility to participate in a clinical trial, thus reducing the burden on families and caregivers.
3H’s vision in supporting successful drug discovery and development is brought about by a patient centric approach which incorporates the latest technology with digital health solutions to cater towards positive patient outcomes.